Effect of etanercept on matrix metalloproteinases and angiogenic vascular endothelial growth factor: a time kinetic study.
Aggarwal
A
A
Panda
S
S
Misra
R
R
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000378:metabolism; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D013997:Time Factors; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D042461:Vascular Endothelial Growth Factor A; D020782:Matrix Metalloproteinases; D000068800:Etanercept